Coronavirus Vaccine Trials | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 09, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 09, 2025

Coronavirus Vaccine Trials

A logo of China's vaccine specialist CanSino Biologics Inc is pictured in Tianjin, China August 17, 2020. REUTERSThomas PeterFile Photo
Coronavirus chronicle

China's CanSino says gets green light to continue Phase III trials

CanSinoBio began the late-stage trial for its one-dose vaccine in Russia in September in partnership with NPO Petrovax Pharm LLC and already has a supply deal with Mexico

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

Seven Chinese-made Covid-19 vaccines enter phase-3 clinical trials: Official

Shouldn’t this be available in America? Photographer: Nicolas Bock/Bloomberg
Coronavirus chronicle

Brazil suspends Sinovac Covid-19 vaccine trial due to adverse event

Demonstrators carry a giant syringe as they protest against Sao Paulo state governor Joao Doria and China's Sinovac potential coronavirus disease (Covid-19) vaccine in Sao Paulo, Brazil, November 1, 2020/ Reuters
Coronavirus chronicle

Brazilians protest mandatory Covid-19 immunization, Chinese vaccine

Photo: Reuters 
Covid-19 in Bangladesh

‘Bangladesh in talks with at least 5 vaccine makers’

FILE PHOTO: A sign is pictured outside Pfizer Headquarters in the Manhattan borough of New York City, New York, U.S., July 22, 2020. REUTERS/Carlo Allegri/File Photo
Coronavirus chronicle

Pfizer, BioNTech propose expanding Covid-19 vaccine trial to 44,000 volunteers

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) started an accelerated "rolling review" of the vaccine at the start of this month as data comes in on safety and efficacy. Photo: Reuters
Coronavirus chronicle

Oxford resumes vaccine trial after pause due to unexplained illness in volunteer

File Photo: US President Donald Trump speaks to reporters as he departs on travel to Phoenix, Arizona from the South Lawn of the White House in Washington, US, May 5, 2020. REUTERS/Kevin Lamarque
Coronavirus chronicle

Trump says without proof that FDA 'deep state' slowing Covid trials

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net